PANTOPRAZOLE SODIUM

PANTOPRAZOLE SODIUM was reported 150070 times

PANTOPRAZOLE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RENAL HAEMANGIOMA 789 0.9900
1 GRIP STRENGTH 128 0.5590
2 REBOUND ACID HYPERSECRETION 1321 0.4363
3 END STAGE RENAL DISEASE 7567 0.4145
4 LUPUS VULGARIS 502 0.3984
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 794 0.3964
6 C-REACTIVE PROTEIN 350 0.3776
7 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 208 0.3708
8 NEPHROGENIC ANAEMIA 1629 0.3513
9 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 365 0.3437
10 CHRONIC KIDNEY DISEASE 24473 0.3218
11 HYPERPARATHYROIDISM SECONDARY 784 0.3126
12 SWOLLEN JOINT COUNT INCREASED 924 0.2895
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 599 0.2888
14 X-RAY ABNORMAL 500 0.2793
15 DUODENAL ULCER PERFORATION 1934 0.2598
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1860 0.2593
17 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1679 0.2583
18 DISLOCATION OF VERTEBRA 589 0.2580
19 MUSCLE INJURY 2062 0.2486
20 RHEUMATIC FEVER 1078 0.2416
21 FACET JOINT SYNDROME 773 0.2372
22 RETINITIS 397 0.2296
23 NEUROLOGIC NEGLECT SYNDROME 126 0.2266
24 PULMONARY VASCULITIS 119 0.2212
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 146 0.2186
26 RHEUMATOID FACTOR POSITIVE 1214 0.2100
27 RENAL INJURY 6217 0.2091
28 FOLLICULITIS 2175 0.2072
29 HELICOBACTER INFECTION 2041 0.1984
30 HYPERCHLORHYDRIA 1113 0.1889
31 PERIPHERAL VENOUS DISEASE 766 0.1874
32 PORPHYRIA ACUTE 256 0.1784
33 PEMPHIGUS 2159 0.1725
34 TUBULOINTERSTITIAL NEPHRITIS 2998 0.1598
35 HAND DEFORMITY 2016 0.1536
36 CAROTID ARTERY THROMBOSIS 128 0.1508
37 HYPERTENSIVE NEPHROPATHY 158 0.1481
38 C-REACTIVE PROTEIN ABNORMAL 924 0.1439
39 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 128 0.1381
40 ADJUSTMENT DISORDER 175 0.1346
41 PERICARDITIS 2189 0.1302
42 BONE EROSION 460 0.1299
43 SYNOVITIS 2310 0.1280
44 BLOOD PRESSURE SYSTOLIC ABNORMAL 293 0.1184
45 TEMPERATURE REGULATION DISORDER 261 0.1170
46 BLOOD PRESSURE DIASTOLIC ABNORMAL 296 0.1163
47 IRRITABLE BOWEL SYNDROME 2435 0.1135
48 SYSTEMIC INFECTION 180 0.1085
49 GLOSSODYNIA 2268 0.1012
50 BURSITIS 1201 0.0989
51 LIP DRY 898 0.0988
52 DRUG TOLERANCE DECREASED 270 0.0961
53 HYPERCHOLESTEROLAEMIA 904 0.0935
54 ACUTE KIDNEY INJURY 13898 0.0907
55 AUTOIMMUNE DISORDER 879 0.0901
56 JOINT RANGE OF MOTION DECREASED 1203 0.0896
57 WOUND INFECTION 970 0.0885
58 ESSENTIAL HYPERTENSION 161 0.0879
59 BREAST CANCER STAGE III 562 0.0867
60 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 194 0.0841
61 RENAL FAILURE 10885 0.0819
62 NEURITIS 126 0.0816
63 REBOUND EFFECT 921 0.0814
64 DIABETIC NEPHROPATHY 178 0.0808
65 WOUND 2260 0.0808
66 IMPAIRED HEALING 2538 0.0772
67 PLEURITIC PAIN 213 0.0771
68 OBSTRUCTIVE SLEEP APNOEA SYNDROME 111 0.0761
69 GRIP STRENGTH DECREASED 639 0.0725
70 MATERNAL EXPOSURE TIMING UNSPECIFIED 266 0.0707
71 FIBROMYALGIA 1667 0.0685
72 BILIARY DYSKINESIA 113 0.0665
73 SYSTEMIC LUPUS ERYTHEMATOSUS 2347 0.0661
74 PUSTULAR PSORIASIS 227 0.0660
75 CONTRAINDICATED PRODUCT ADMINISTERED 2001 0.0660
76 NEPHROPATHY 609 0.0652
77 INFUSION SITE REACTION 192 0.0642
78 OBESITY 1024 0.0642
79 EXOSTOSIS 576 0.0630
80 RESPIRATORY SYMPTOM 173 0.0608
81 PULMONARY FIBROSIS 1150 0.0599
82 BLEPHAROSPASM 377 0.0598
83 LIVE BIRTH 491 0.0586
84 LOWER RESPIRATORY TRACT INFECTION 2651 0.0582
85 SCIATICA 929 0.0582
86 WALKING AID USER 378 0.0573
87 CHRONIC SINUSITIS 211 0.0562
88 PERSONALITY DISORDER 146 0.0557
89 TYPE 2 DIABETES MELLITUS 1868 0.0554
90 ULCER HAEMORRHAGE 375 0.0554
91 LOWER LIMB FRACTURE 1054 0.0548
92 GASTROOESOPHAGEAL REFLUX DISEASE 4388 0.0545
93 PRESCRIBED OVERDOSE 1043 0.0538
94 BREATH SOUNDS ABNORMAL 264 0.0535
95 RADICULOPATHY 140 0.0531
96 LIVER INJURY 1303 0.0530
97 FOOD ALLERGY 402 0.0520
98 RED BLOOD CELL SEDIMENTATION RATE INCREASED 576 0.0520
99 DRUG SCREEN FALSE POSITIVE 138 0.0498
100 LUNG OPACITY 130 0.0493
101 RASH VESICULAR 237 0.0490
102 CHOLECYSTITIS CHRONIC 325 0.0485
103 ARTHROPATHY 2657 0.0478
104 RENAL CYST 376 0.0473
105 STOMATITIS 2867 0.0472
106 FULL BLOOD COUNT ABNORMAL 495 0.0468
107 INFUSION RELATED REACTION 3093 0.0466
108 ATELECTASIS 446 0.0461
109 BLISTER 2579 0.0459
110 BENIGN PROSTATIC HYPERPLASIA 237 0.0459
111 OBSTRUCTIVE AIRWAYS DISORDER 510 0.0458
112 NIGHT SWEATS 1475 0.0457
113 AORTIC ARTERIOSCLEROSIS 116 0.0450
114 NORMOCHROMIC NORMOCYTIC ANAEMIA 134 0.0446
115 FORCED EXPIRATORY VOLUME DECREASED 126 0.0444
116 INFUSION SITE HAEMORRHAGE 146 0.0443
117 RALES 257 0.0442
118 OSTEOARTHRITIS 1876 0.0442
119 HEPATIC ENZYME INCREASED 2991 0.0438
120 RENAL TUBULAR NECROSIS 430 0.0438
121 PEPTIC ULCER 145 0.0437
122 BREAST CANCER STAGE II 362 0.0435
123 THERAPEUTIC PRODUCT EFFECT DECREASED 1936 0.0432
124 LUPUS-LIKE SYNDROME 391 0.0431
125 PNEUMONIA VIRAL 135 0.0423
126 HIATUS HERNIA 536 0.0414
127 RHEUMATOID NODULE 114 0.0413
128 FOOT DEFORMITY 455 0.0410
129 HAEMORRHAGIC ANAEMIA 177 0.0402
130 DIASTOLIC DYSFUNCTION 124 0.0401
131 MUSCLE SPASTICITY 493 0.0401
132 THERAPEUTIC REACTION TIME DECREASED 117 0.0401
133 ARTERIOSCLEROSIS CORONARY ARTERY 265 0.0400
134 WHEEZING 2368 0.0399
135 SPUTUM DISCOLOURED 377 0.0397
136 INFUSION SITE PRURITUS 123 0.0389
137 PSORIATIC ARTHROPATHY 1569 0.0386
138 SEASONAL ALLERGY 547 0.0386
139 SINUSITIS 3954 0.0385
140 BLOOD CHOLESTEROL INCREASED 1797 0.0385
141 INFUSION SITE SWELLING 242 0.0384
142 FOETAL DEATH 198 0.0381
143 DIABETIC NEUROPATHY 189 0.0381
144 DIVERTICULUM INTESTINAL 165 0.0377
145 AORTIC VALVE INCOMPETENCE 159 0.0373
146 DISCOMFORT 2280 0.0373
147 INFUSION SITE ERYTHEMA 311 0.0369
148 ISCHAEMIC CARDIOMYOPATHY 113 0.0368
149 EAR PAIN 715 0.0367
150 BRONCHIECTASIS 247 0.0366
151 VASCULAR DEVICE INFECTION 166 0.0366
152 SPINAL OSTEOARTHRITIS 321 0.0365
153 TRICUSPID VALVE INCOMPETENCE 290 0.0365
154 HEPATIC CIRRHOSIS 683 0.0363
155 BLOOD PRESSURE SYSTOLIC INCREASED 707 0.0362
156 JOINT DISLOCATION 382 0.0361
157 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 611 0.0359
158 GAIT INABILITY 1201 0.0359
159 COELIAC DISEASE 350 0.0356
160 IMMUNODEFICIENCY 531 0.0356
161 HIP ARTHROPLASTY 544 0.0355
162 MITRAL VALVE INCOMPETENCE 401 0.0354
163 LEFT VENTRICULAR HYPERTROPHY 150 0.0350
164 ONYCHOMADESIS 146 0.0348
165 ARTERIOSCLEROSIS 327 0.0347
166 IRON DEFICIENCY ANAEMIA 320 0.0346
167 SWELLING 3234 0.0345
168 ILL-DEFINED DISORDER 2091 0.0344
169 BLOOD PRESSURE DIASTOLIC DECREASED 254 0.0344
170 HYPERLIPIDAEMIA 409 0.0342
171 THERAPEUTIC AGENT TOXICITY 114 0.0342
172 GASTROINTESTINAL DISORDER 3062 0.0341
173 ANTINUCLEAR ANTIBODY POSITIVE 111 0.0341
174 INFUSION SITE PAIN 439 0.0340
175 LUNG DISORDER 1660 0.0338
176 GANGRENE 202 0.0335
177 HYPERVOLAEMIA 164 0.0332
178 OEDEMA 1781 0.0328
179 C-REACTIVE PROTEIN INCREASED 1188 0.0326
180 JOINT SWELLING 3926 0.0325
181 CAROTID ARTERY STENOSIS 113 0.0323
182 MUSCULOSKELETAL PAIN 1685 0.0321
183 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 161 0.0318
184 AZOTAEMIA 127 0.0318
185 HAEMATOCRIT DECREASED 628 0.0316
186 CONTUSION 3027 0.0314
187 INJURY 2201 0.0313
188 DRUG INTOLERANCE 3003 0.0311
189 LIVER DISORDER 1376 0.0310
190 SYNOVIAL CYST 143 0.0309
191 BLOOD MAGNESIUM DECREASED 266 0.0308
192 RHEUMATOID ARTHRITIS 3498 0.0308
193 TASTE DISORDER 622 0.0306
194 JOINT EFFUSION 211 0.0306
195 BODY TEMPERATURE DECREASED 301 0.0305
196 DIVERTICULUM 216 0.0304
197 RENAL FAILURE CHRONIC 233 0.0303
198 CORONARY ARTERY DISEASE 909 0.0300
199 PERIPHERAL VASCULAR DISORDER 154 0.0299
200 CANDIDIASIS 119 0.0296
201 MYOSITIS 266 0.0296
202 DYSPNOEA EXERTIONAL 1116 0.0296
203 RHINITIS ALLERGIC 131 0.0294
204 UPPER RESPIRATORY TRACT INFECTION 1359 0.0294
205 ROAD TRAFFIC ACCIDENT 1230 0.0294
206 ARTERIAL OCCLUSIVE DISEASE 229 0.0291
207 KNEE ARTHROPLASTY 613 0.0291
208 GENERAL PHYSICAL HEALTH DETERIORATION 3365 0.0291
209 DRUG TOLERANCE 147 0.0290
210 OESOPHAGITIS 317 0.0290
211 DYSLIPIDAEMIA 147 0.0289
212 GASTRITIS 756 0.0287
213 SINUS CONGESTION 387 0.0286
214 NAIL DISORDER 249 0.0284
215 INTERVERTEBRAL DISC DEGENERATION 263 0.0284
216 FREQUENT BOWEL MOVEMENTS 767 0.0284
217 CARDIOMEGALY 344 0.0279
218 BACK INJURY 303 0.0278
219 WEIGHT FLUCTUATION 291 0.0278
220 LUNG INFILTRATION 244 0.0276
221 PROTHROMBIN TIME PROLONGED 165 0.0276
222 PERIPHERAL SWELLING 4249 0.0276
223 POOR VENOUS ACCESS 285 0.0275
224 NEUROLOGICAL SYMPTOM 157 0.0274
225 ACUTE RESPIRATORY FAILURE 525 0.0273
226 DYSPEPSIA 2680 0.0272
227 FLANK PAIN 255 0.0272
228 DELIRIUM 944 0.0272
229 OSTEOPOROSIS 1118 0.0272
230 PRESCRIBED UNDERDOSE 539 0.0270
231 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 463 0.0270
232 THERAPY NON-RESPONDER 1208 0.0268
233 ASPIRATION 294 0.0268
234 BLOOD PRESSURE FLUCTUATION 643 0.0268
235 VITAMIN D DEFICIENCY 261 0.0267
236 BLOOD CALCIUM INCREASED 234 0.0267
237 MULTIPLE INJURIES 167 0.0265
238 LOWER GASTROINTESTINAL HAEMORRHAGE 196 0.0265
239 ASTHMA 2986 0.0264
240 DIALYSIS 373 0.0263
241 SLEEP DISORDER 1843 0.0261
242 ABDOMINAL HERNIA 119 0.0261
243 FAILURE TO THRIVE 135 0.0260
244 ELECTROLYTE IMBALANCE 302 0.0260
245 GASTRITIS EROSIVE 121 0.0259
246 SENSORY LOSS 208 0.0258
247 BLOOD PRESSURE DIASTOLIC INCREASED 119 0.0258
248 INFECTION 3730 0.0257
249 SLEEP APNOEA SYNDROME 491 0.0257
250 HYPOMAGNESAEMIA 358 0.0257
251 EAR INFECTION 683 0.0256
252 BODY TEMPERATURE INCREASED 523 0.0256
253 TENDERNESS 266 0.0255
254 PULMONARY ALVEOLAR HAEMORRHAGE 143 0.0255
255 BACK DISORDER 412 0.0253
256 ORAL CANDIDIASIS 333 0.0253
257 ULCER 402 0.0252
258 MUSCULOSKELETAL STIFFNESS 2212 0.0252
259 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1313 0.0251
260 ECONOMIC PROBLEM 380 0.0250
261 RESPIRATORY DISORDER 750 0.0250
262 RECTAL HAEMORRHAGE 1071 0.0249
263 IRON DEFICIENCY 112 0.0249
264 FLUID RETENTION 1256 0.0247
265 HAEMORRHOIDS 481 0.0246
266 CLOSTRIDIUM DIFFICILE COLITIS 261 0.0246
267 TROPONIN INCREASED 187 0.0246
268 UPPER GASTROINTESTINAL HAEMORRHAGE 412 0.0245
269 PRODUCTIVE COUGH 1168 0.0244
270 RESPIRATORY TRACT CONGESTION 388 0.0244
271 OEDEMA PERIPHERAL 2972 0.0244
272 SCOLIOSIS 151 0.0244
273 GALLBLADDER DISORDER 435 0.0243
274 HYPOKALAEMIA 1123 0.0243
275 BLOOD ALBUMIN DECREASED 192 0.0242
276 GASTRIC ULCER 459 0.0241
277 DRUG SCREEN POSITIVE 190 0.0240
278 CONFUSIONAL STATE 3880 0.0240
279 PREGNANCY 480 0.0239
280 MACULAR DEGENERATION 286 0.0239
281 FAECES SOFT 174 0.0239
282 INFLAMMATION 1230 0.0238
283 RESPIRATORY RATE INCREASED 211 0.0237
284 HYPOVOLAEMIA 139 0.0237
285 MOBILITY DECREASED 1702 0.0237
286 DECUBITUS ULCER 193 0.0237
287 JOINT STIFFNESS 621 0.0236
288 SMALL INTESTINAL OBSTRUCTION 291 0.0236
289 PULMONARY HYPERTENSION 491 0.0235
290 NASOPHARYNGITIS 4340 0.0235
291 ABDOMINAL DISCOMFORT 3949 0.0235
292 GENERAL SYMPTOM 176 0.0235
293 HAEMOPTYSIS 650 0.0233
294 SINUS DISORDER 461 0.0233
295 INTENTIONAL PRODUCT USE ISSUE 2035 0.0232
296 CHOLECYSTITIS ACUTE 131 0.0231
297 ANAL FISSURE 123 0.0229
298 MICTURITION URGENCY 261 0.0228
299 DRY MOUTH 1848 0.0228
300 HYPOXIA 801 0.0227
301 MULTIPLE ALLERGIES 178 0.0227
302 APHTHOUS ULCER 176 0.0227
303 OXYGEN SATURATION DECREASED 1272 0.0226
304 MUCOUS STOOLS 112 0.0226
305 NOCTURIA 274 0.0225
306 HEPATIC STEATOSIS 420 0.0225
307 CACHEXIA 116 0.0225
308 POLYP 147 0.0224
309 PULMONARY MASS 333 0.0223
310 HEMIPLEGIA 185 0.0222
311 RENAL FAILURE ACUTE 939 0.0221
312 MALNUTRITION 247 0.0221
313 GASTROINTESTINAL HAEMORRHAGE 1842 0.0220
314 INFUSION SITE EXTRAVASATION 137 0.0220
315 UROSEPSIS 203 0.0220
316 RED BLOOD CELL COUNT DECREASED 629 0.0220
317 CHOLECYSTITIS 262 0.0220
318 RENAL IMPAIRMENT 1847 0.0220
319 CHEST PAIN 4059 0.0219
320 ARTHRITIS 1723 0.0219
321 HEART RATE DECREASED 768 0.0218
322 ANGINA PECTORIS 624 0.0218
323 VASCULITIS 252 0.0216
324 CLOSTRIDIUM DIFFICILE INFECTION 471 0.0216
325 ATRIAL FLUTTER 172 0.0215
326 MOTOR DYSFUNCTION 219 0.0215
327 ELECTROCARDIOGRAM ABNORMAL 168 0.0214
328 BLOOD POTASSIUM DECREASED 643 0.0214
329 HYDRONEPHROSIS 160 0.0214
330 CHOLELITHIASIS 700 0.0213
331 UPPER-AIRWAY COUGH SYNDROME 174 0.0211
332 HAEMODIALYSIS 177 0.0211
333 HYPERTENSION 4456 0.0210
334 BRONCHITIS 1554 0.0210
335 PRE-EXISTING CONDITION IMPROVED 131 0.0210
336 LIVER FUNCTION TEST INCREASED 450 0.0209
337 HYPERSENSITIVITY 3890 0.0209
338 GOUT 376 0.0209
339 WEIGHT INCREASED 4672 0.0208
340 CARDIAC MURMUR 179 0.0207
341 CYSTITIS 657 0.0206
342 DISABILITY 408 0.0206
343 ABDOMINAL PAIN UPPER 4232 0.0205
344 LARGE INTESTINE POLYP 142 0.0205
345 BLOOD IRON DECREASED 243 0.0205
346 PRODUCT ADMINISTRATION INTERRUPTED 160 0.0204
347 BLOOD CALCIUM DECREASED 229 0.0203
348 HAEMATOCHEZIA 1122 0.0203
349 PLEURAL EFFUSION 1233 0.0202
350 LYMPHOEDEMA 140 0.0202
351 EMPHYSEMA 204 0.0202
352 GASTROENTERITIS 295 0.0202
353 IMPAIRED GASTRIC EMPTYING 274 0.0201
354 POSTOPERATIVE WOUND INFECTION 135 0.0200
355 WHITE BLOOD CELL COUNT INCREASED 764 0.0199
356 NODULE 258 0.0197
357 BONE DISORDER 360 0.0197
358 ATRIAL FIBRILLATION 1923 0.0197
359 TREATMENT FAILURE 1633 0.0197
360 HYPERCALCAEMIA 242 0.0196
361 ABDOMINAL PAIN 4545 0.0195
362 BLOOD UREA INCREASED 327 0.0195
363 BLOOD SODIUM DECREASED 367 0.0195
364 PANCREATITIS 1029 0.0194
365 MENTAL STATUS CHANGES 540 0.0194
366 LIGAMENT SPRAIN 192 0.0194
367 MELAENA 427 0.0194
368 GLUCOSE TOLERANCE IMPAIRED 114 0.0193
369 BLOOD URIC ACID INCREASED 111 0.0192
370 HAEMOGLOBIN DECREASED 1973 0.0192
371 INTERVERTEBRAL DISC PROTRUSION 420 0.0192
372 PNEUMONIA 6216 0.0192
373 OSTEOPENIA 291 0.0192
374 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 919 0.0191
375 HYPOCALCAEMIA 362 0.0191
376 HEMIPARESIS 324 0.0191
377 MATERNAL EXPOSURE DURING PREGNANCY 1701 0.0191
378 EATING DISORDER 405 0.0190
379 MIGRAINE 1815 0.0190
380 POLYURIA 155 0.0189
381 ANAL INCONTINENCE 170 0.0189
382 RIGHT VENTRICULAR FAILURE 132 0.0188
383 MUSCULOSKELETAL CHEST PAIN 291 0.0188
384 PYREXIA 6495 0.0188
385 VITAMIN D DECREASED 160 0.0187
386 ANAEMIA 3569 0.0187
387 VENTRICULAR EXTRASYSTOLES 194 0.0187
388 CARDIAC FAILURE CONGESTIVE 1500 0.0187
389 HAEMATEMESIS 472 0.0186
390 ANGINA UNSTABLE 121 0.0186
391 HYPONATRAEMIA 1048 0.0186
392 TYPE 1 DIABETES MELLITUS 112 0.0186
393 PYELONEPHRITIS 161 0.0186
394 ABNORMAL FAECES 152 0.0185
395 DIVERTICULITIS 513 0.0185
396 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 163 0.0184
397 SUPRAVENTRICULAR TACHYCARDIA 176 0.0184
398 SKIN HAEMORRHAGE 272 0.0183
399 RIB FRACTURE 377 0.0183
400 DERMATITIS CONTACT 209 0.0183
401 HYPOPHOSPHATAEMIA 135 0.0182
402 RESPIRATORY TRACT INFECTION 474 0.0182
403 DEHYDRATION 2425 0.0182
404 HAEMATURIA 619 0.0181
405 COLITIS ULCERATIVE 805 0.0180
406 JOINT INJURY 384 0.0180
407 ILEUS 223 0.0179
408 SKIN LACERATION 195 0.0179
409 HYPERKALAEMIA 625 0.0178
410 HYPOAESTHESIA 2664 0.0178
411 AMNESIA 1156 0.0178
412 PERICARDIAL EFFUSION 410 0.0177
413 SECRETION DISCHARGE 222 0.0177
414 GASTROENTERITIS VIRAL 320 0.0177
415 CARPAL TUNNEL SYNDROME 248 0.0177
416 DEFAECATION URGENCY 124 0.0177
417 ORAL PAIN 396 0.0177
418 LEFT VENTRICULAR DYSFUNCTION 118 0.0176
419 CARDIOMYOPATHY 260 0.0176
420 POST PROCEDURAL INFECTION 143 0.0176
421 MYOCARDIAL ISCHAEMIA 200 0.0176
422 HEART RATE IRREGULAR 396 0.0175
423 SKIN ULCER 453 0.0175
424 CROHN'S DISEASE 120 0.0175
425 HYPOTHYROIDISM 559 0.0175
426 DYSURIA 644 0.0175
427 WEIGHT DECREASED 4881 0.0175
428 ROTATOR CUFF SYNDROME 224 0.0174
429 NEPHROLITHIASIS 798 0.0174
430 MAJOR DEPRESSION 127 0.0174
431 CORONARY ARTERY OCCLUSION 238 0.0173
432 DYSPNOEA 9796 0.0173
433 ASTHENIA 6490 0.0172
434 LIPASE INCREASED 132 0.0172
435 LIMB INJURY 467 0.0172
436 TOOTH ABSCESS 175 0.0172
437 CELLULITIS 866 0.0172
438 DUODENAL ULCER 121 0.0171
439 ANOREXIA 221 0.0171
440 URINARY TRACT INFECTION 2919 0.0171
441 ASCITES 503 0.0171
442 DECREASED APPETITE 3965 0.0171
443 CHOLECYSTECTOMY 194 0.0170
444 MULTI-ORGAN FAILURE 293 0.0169
445 ARTHRALGIA 7044 0.0169
446 BLOOD TEST ABNORMAL 238 0.0169
447 AFFECT LABILITY 163 0.0169
448 COORDINATION ABNORMAL 236 0.0169
449 KIDNEY INFECTION 332 0.0169
450 MUSCULAR WEAKNESS 1911 0.0168
451 BLOOD PRESSURE INCREASED 2556 0.0167
452 CONCUSSION 129 0.0166
453 INTERNATIONAL NORMALISED RATIO INCREASED 472 0.0165
454 FULL BLOOD COUNT DECREASED 332 0.0165
455 FLATULENCE 932 0.0164
456 TRANSIENT ISCHAEMIC ATTACK 554 0.0164
457 SINUS TACHYCARDIA 233 0.0164
458 HOSPICE CARE 162 0.0164
459 PAIN 10045 0.0163
460 ALOPECIA 3208 0.0163
461 GENERALISED OEDEMA 202 0.0163
462 SPLENOMEGALY 190 0.0162
463 BLOOD POTASSIUM INCREASED 263 0.0162
464 INCONTINENCE 171 0.0162
465 RHINORRHOEA 1045 0.0162
466 BACK PAIN 3750 0.0161
467 LEUKOCYTOSIS 292 0.0161
468 EPILEPSY 493 0.0161
469 COUGH 4520 0.0161
470 CHEST DISCOMFORT 1649 0.0161
471 DIZZINESS POSTURAL 156 0.0161
472 DIARRHOEA HAEMORRHAGIC 150 0.0160
473 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1141 0.0160
474 FOOT FRACTURE 304 0.0160
475 WRIST FRACTURE 192 0.0160
476 PULMONARY EMBOLISM 1521 0.0160
477 CONDITION AGGRAVATED 4854 0.0159
478 DEFORMITY 149 0.0159
479 INTERNAL HAEMORRHAGE 182 0.0159
480 NERVE COMPRESSION 147 0.0159
481 ADRENAL INSUFFICIENCY 193 0.0159
482 DYSPHONIA 930 0.0159
483 FAECES DISCOLOURED 344 0.0159
484 PULMONARY CONGESTION 209 0.0158
485 PRESYNCOPE 385 0.0158
486 HAND FRACTURE 112 0.0158
487 URINE OUTPUT DECREASED 138 0.0158
488 RETCHING 336 0.0157
489 ABDOMINAL DISTENSION 1645 0.0157
490 RHINITIS 127 0.0157
491 NECK PAIN 876 0.0157
492 DIABETES MELLITUS 1193 0.0156
493 INSURANCE ISSUE 239 0.0156
494 SPINAL COMPRESSION FRACTURE 129 0.0156
495 ACUTE MYOCARDIAL INFARCTION 460 0.0156
496 HYPOPHAGIA 398 0.0156
497 TRANSFUSION 163 0.0155
498 PELVIC FRACTURE 121 0.0155
499 PANCYTOPENIA 865 0.0155
500 CONSTIPATION 3374 0.0155
501 CANDIDA INFECTION 260 0.0154
502 PULMONARY OEDEMA 689 0.0154
503 THROMBOCYTOPENIA 1719 0.0154
504 VENTRICULAR TACHYCARDIA 253 0.0153
505 BLOOD CREATININE INCREASED 1000 0.0153
506 DEEP VEIN THROMBOSIS 995 0.0153
507 POST PROCEDURAL COMPLICATION 294 0.0153
508 DIABETES MELLITUS INADEQUATE CONTROL 271 0.0153
509 PAIN IN JAW 433 0.0153
510 GASTROINTESTINAL PAIN 168 0.0153
511 SEPSIS 1699 0.0152
512 OROPHARYNGEAL PAIN 1410 0.0152
513 THROAT IRRITATION 683 0.0152
514 HYPOTENSION 3051 0.0152
515 RENAL PAIN 161 0.0152
516 FLUID OVERLOAD 221 0.0152
517 BACTERIAL INFECTION 283 0.0152
518 LABORATORY TEST ABNORMAL 447 0.0151
519 URTICARIA 2536 0.0151
520 ATRIOVENTRICULAR BLOCK 117 0.0151
521 RESTLESS LEGS SYNDROME 275 0.0151
522 VOMITING 7099 0.0151
523 PROTEINURIA 287 0.0151
524 BACTERAEMIA 179 0.0151
525 NEURALGIA 366 0.0150
526 PHOTOPHOBIA 283 0.0150
527 RESPIRATORY SYNCYTIAL VIRUS INFECTION 131 0.0150
528 TOOTH INFECTION 198 0.0150
529 DYSPHAGIA 1425 0.0150
530 MUSCLE SPASMS 2752 0.0150
531 EYE PAIN 846 0.0150
532 FATIGUE 11674 0.0150
533 FISTULA 168 0.0149
534 DIARRHOEA 9646 0.0149
535 SNEEZING 335 0.0149
536 PARAESTHESIA ORAL 215 0.0149
537 GLOMERULAR FILTRATION RATE DECREASED 183 0.0149
538 DEPRESSION 3383 0.0149
539 POLYNEUROPATHY 178 0.0149
540 COLITIS 562 0.0148
541 STAPHYLOCOCCAL INFECTION 489 0.0148
542 TOXIC EPIDERMAL NECROLYSIS 225 0.0148
543 GROIN PAIN 130 0.0148
544 URINARY INCONTINENCE 438 0.0148
545 INCREASED TENDENCY TO BRUISE 136 0.0148
546 BLOOD ALKALINE PHOSPHATASE INCREASED 367 0.0148
547 HEPATOMEGALY 145 0.0147
548 MULTIPLE FRACTURES 242 0.0147
549 ANXIETY 4192 0.0147
550 ESCHERICHIA INFECTION 121 0.0147
551 TACHYPNOEA 200 0.0147
552 ERUCTATION 284 0.0147
553 MIDDLE INSOMNIA 273 0.0146
554 GASTROINTESTINAL INFECTION 131 0.0146
555 COAGULOPATHY 243 0.0146
556 THROMBOSIS 1173 0.0146
557 EXPOSURE DURING PREGNANCY 906 0.0146
558 COVID-19 PNEUMONIA 172 0.0146
559 SEPTIC SHOCK 633 0.0145
560 MUSCULOSKELETAL DISCOMFORT 250 0.0145
561 HYPERGLYCAEMIA 529 0.0145
562 CATARACT 864 0.0145
563 RENAL DISORDER 675 0.0145
564 SINUS BRADYCARDIA 140 0.0145
565 PAIN IN EXTREMITY 4263 0.0145
566 PSEUDOMONAS INFECTION 124 0.0144
567 NASAL CONGESTION 848 0.0144
568 MEDICATION ERROR 801 0.0144
569 FALL 4784 0.0144
570 HEPATIC ENCEPHALOPATHY 134 0.0143
571 FEELING HOT 880 0.0143
572 FACIAL PAIN 128 0.0143
573 EPISTAXIS 1069 0.0143
574 ANKLE FRACTURE 221 0.0143
575 CYST 177 0.0142
576 INTESTINAL OBSTRUCTION 536 0.0142
577 LIVER FUNCTION TEST ABNORMAL 413 0.0142
578 RESPIRATORY FAILURE 1025 0.0140
579 PNEUMONIA BACTERIAL 129 0.0140
580 LEUKOPENIA 702 0.0140
581 PARAESTHESIA 2197 0.0140
582 MUSCLE STRAIN 120 0.0139
583 HERNIA 268 0.0138
584 VIRAL INFECTION 460 0.0138
585 HAEMATOMA 358 0.0138
586 BLOOD BILIRUBIN INCREASED 373 0.0138
587 HYPERTENSIVE CRISIS 153 0.0137
588 PANCREATITIS ACUTE 308 0.0137
589 SYNCOPE 1368 0.0137
590 ABSCESS 218 0.0136
591 APHASIA 412 0.0136
592 PRURITUS 5234 0.0136
593 SCAR 233 0.0136
594 NAUSEA 10755 0.0136
595 INSOMNIA 3619 0.0136
596 MEMORY IMPAIRMENT 1865 0.0136
597 HEADACHE 8495 0.0135
598 HEART RATE INCREASED 1342 0.0135
599 CONJUNCTIVITIS 251 0.0135
600 RASH 5898 0.0135
601 ACUTE CORONARY SYNDROME 112 0.0135
602 ANHEDONIA 355 0.0135
603 FEBRILE NEUTROPENIA 895 0.0135
604 BODY HEIGHT DECREASED 144 0.0135
605 BASAL CELL CARCINOMA 210 0.0134
606 RASH PRURITIC 726 0.0134
607 EJECTION FRACTION DECREASED 208 0.0134
608 LIMB DISCOMFORT 414 0.0134
609 GAIT DISTURBANCE 2559 0.0134
610 INFLUENZA 1491 0.0134
611 PRODUCT USE ISSUE 2507 0.0133
612 ABDOMINAL PAIN LOWER 337 0.0133
613 PNEUMOTHORAX 211 0.0133
614 RASH ERYTHEMATOUS 635 0.0133
615 HEPATITIS 339 0.0132
616 PETECHIAE 138 0.0132
617 ASPARTATE AMINOTRANSFERASE INCREASED 702 0.0132
618 DEVICE RELATED INFECTION 203 0.0132
619 PULMONARY ARTERIAL HYPERTENSION 191 0.0132
620 SKIN INFECTION 147 0.0131
621 OSTEOMYELITIS 237 0.0131
622 TRANSAMINASES INCREASED 291 0.0131
623 BLOOD PRESSURE ABNORMAL 260 0.0131
624 MOUTH ULCERATION 275 0.0130
625 UPPER LIMB FRACTURE 260 0.0130
626 BLOOD URINE PRESENT 247 0.0130
627 SWOLLEN TONGUE 405 0.0130
628 PHARYNGITIS STREPTOCOCCAL 140 0.0129
629 HIP FRACTURE 416 0.0129
630 POLLAKIURIA 537 0.0129
631 HEREDITARY ANGIOEDEMA 138 0.0128
632 FEELING JITTERY 245 0.0128
633 PNEUMONIA ASPIRATION 321 0.0128
634 DRUG-INDUCED LIVER INJURY 403 0.0128
635 HEAD INJURY 406 0.0128
636 HERPES ZOSTER 737 0.0128
637 PULMONARY THROMBOSIS 139 0.0127
638 LOCALISED INFECTION 308 0.0127
639 LYMPHOCYTE COUNT DECREASED 225 0.0127
640 DERMATITIS ALLERGIC 160 0.0127
641 DIZZINESS 6334 0.0127
642 GASTRIC DISORDER 435 0.0127
643 URINARY RETENTION 422 0.0126
644 SUBDURAL HAEMATOMA 181 0.0126
645 POOR QUALITY SLEEP 272 0.0126
646 FUNGAL INFECTION 421 0.0126
647 PLATELET COUNT DECREASED 1344 0.0126
648 GASTRIC HAEMORRHAGE 145 0.0126
649 EAR DISCOMFORT 129 0.0126
650 BLOOD LACTATE DEHYDROGENASE INCREASED 199 0.0125
651 DYSARTHRIA 472 0.0125
652 SCRATCH 132 0.0125
653 PROCEDURAL PAIN 347 0.0125
654 BLOOD TRIGLYCERIDES INCREASED 221 0.0125
655 PLATELET COUNT INCREASED 163 0.0125
656 DENTAL CARIES 138 0.0125
657 BLOOD PRESSURE DECREASED 827 0.0124
658 HYPERSOMNIA 356 0.0124
659 TACHYCARDIA 1098 0.0123
660 EYE INFECTION 139 0.0123
661 MASS 172 0.0123
662 PRODUCT DISTRIBUTION ISSUE 114 0.0123
663 SPINAL DISORDER 116 0.0122
664 BIPOLAR DISORDER 133 0.0122
665 HYPERHIDROSIS 1576 0.0122
666 ALANINE AMINOTRANSFERASE INCREASED 749 0.0122
667 ORAL DISCOMFORT 169 0.0121
668 OVARIAN CYST 121 0.0121
669 BLADDER DISORDER 120 0.0121
670 FEMUR FRACTURE 374 0.0121
671 APHONIA 168 0.0120
672 LACERATION 113 0.0120
673 BONE PAIN 703 0.0120
674 WHITE BLOOD CELL COUNT DECREASED 1300 0.0120
675 METABOLIC ACIDOSIS 383 0.0120
676 GAMMA-GLUTAMYLTRANSFERASE INCREASED 265 0.0119
677 MALAISE 5228 0.0119
678 ORAL HERPES 232 0.0119
679 TOOTH FRACTURE 131 0.0119
680 PALPITATIONS 1391 0.0119
681 CARDIAC FAILURE 952 0.0118
682 ORTHOSTATIC HYPOTENSION 206 0.0118
683 SKIN LESION 323 0.0118
684 PRODUCT PRESCRIBING ERROR 280 0.0117
685 DISORIENTATION 463 0.0117
686 VAGINAL DISCHARGE 118 0.0117
687 TOOTH DISORDER 259 0.0116
688 DRY THROAT 118 0.0116
689 ANKYLOSING SPONDYLITIS 153 0.0116
690 BRADYCARDIA 612 0.0115
691 FEAR 310 0.0115
692 ILLNESS 1186 0.0115
693 DRUG ERUPTION 204 0.0115
694 CARDIOGENIC SHOCK 165 0.0115
695 THYROID DISORDER 177 0.0115
696 PHARYNGITIS 142 0.0114
697 SWELLING FACE 745 0.0114
698 SPINAL PAIN 134 0.0114
699 UNRESPONSIVE TO STIMULI 294 0.0114
700 RASH MACULO-PAPULAR 253 0.0114
701 TENDONITIS 176 0.0114
702 METASTASES TO LIVER 199 0.0113
703 NEUROPATHY PERIPHERAL 1075 0.0113
704 MUCOSAL INFLAMMATION 295 0.0113
705 CHILLS 1315 0.0112
706 PNEUMONITIS 305 0.0112
707 FEEDING DISORDER 227 0.0112
708 CARDIOVASCULAR DISORDER 284 0.0112
709 FEELING COLD 311 0.0112
710 RESPIRATORY DISTRESS 308 0.0111
711 HYPOKINESIA 162 0.0111
712 ARRHYTHMIA 528 0.0111
713 DEMENTIA 311 0.0111
714 COVID-19 1950 0.0111
715 SPINAL FRACTURE 222 0.0111
716 ENCEPHALOPATHY 272 0.0111
717 DRUG LEVEL DECREASED 112 0.0110
718 PALLOR 299 0.0110
719 VENTRICULAR FIBRILLATION 122 0.0110
720 HEAD DISCOMFORT 194 0.0109
721 HEPATIC FAILURE 330 0.0109
722 DYSSTASIA 319 0.0109
723 BLOOD COUNT ABNORMAL 165 0.0109
724 NERVE INJURY 121 0.0109
725 HYPOAESTHESIA ORAL 164 0.0109
726 BRONCHOSPASM 155 0.0109
727 TEMPERATURE INTOLERANCE 112 0.0108
728 BALANCE DISORDER 932 0.0108
729 COLD SWEAT 190 0.0108
730 CHOKING 210 0.0108
731 TOOTHACHE 193 0.0107
732 DECREASED ACTIVITY 115 0.0106
733 CARDIAC DISORDER 994 0.0106
734 PLASMA CELL MYELOMA 413 0.0106
735 QUALITY OF LIFE DECREASED 142 0.0106
736 MYALGIA 1795 0.0105
737 CIRCULATORY COLLAPSE 179 0.0105
738 POST PROCEDURAL HAEMORRHAGE 122 0.0105
739 HYPOGLYCAEMIA 506 0.0104
740 LETHARGY 600 0.0104
741 INFLUENZA LIKE ILLNESS 854 0.0104
742 LOSS OF CONSCIOUSNESS 1329 0.0104
743 TREMOR 1720 0.0104
744 OCULAR DISCOMFORT 115 0.0102
745 CHROMATURIA 231 0.0102
746 SARS-COV-2 TEST POSITIVE 135 0.0102
747 CYTOKINE RELEASE SYNDROME 205 0.0102
748 BRAIN FOG 160 0.0102
749 PERIPHERAL COLDNESS 140 0.0102
750 GASTRIC CANCER 258 0.0102
751 MYOCARDIAL INFARCTION 1774 0.0102
752 INTESTINAL PERFORATION 114 0.0101
753 BURNING SENSATION 711 0.0101
754 DRUG TOXICITY 138 0.0101
755 JAUNDICE 272 0.0101
756 ADVERSE EVENT 931 0.0101
757 ACTIVITIES OF DAILY LIVING IMPAIRED 199 0.0100
758 LYMPHADENOPATHY 353 0.0100
759 TOOTH EXTRACTION 124 0.0100
760 VERTIGO 607 0.0099
761 NEUTROPHIL COUNT DECREASED 405 0.0099
762 PSORIASIS 1291 0.0099
763 CEREBROVASCULAR ACCIDENT 1671 0.0099
764 IMPAIRED DRIVING ABILITY 112 0.0098
765 UNEVALUABLE EVENT 744 0.0098
766 HOT FLUSH 740 0.0098
767 PHOTOSENSITIVITY REACTION 162 0.0098
768 TINNITUS 450 0.0098
769 MUSCLE TIGHTNESS 158 0.0097
770 VISUAL IMPAIRMENT 1208 0.0097
771 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1749 0.0097
772 CONVULSION 555 0.0097
773 RESTLESSNESS 355 0.0097
774 METASTASES TO BONE 159 0.0097
775 MOVEMENT DISORDER 311 0.0097
776 ADVERSE DRUG REACTION 868 0.0097
777 PANIC ATTACK 352 0.0096
778 EOSINOPHILIA 168 0.0096
779 CHOLESTASIS 184 0.0096
780 ACUTE RESPIRATORY DISTRESS SYNDROME 169 0.0095
781 FLUSHING 970 0.0095
782 MYELODYSPLASTIC SYNDROME 138 0.0095
783 DIPLOPIA 246 0.0095
784 DRY EYE 471 0.0094
785 LACRIMATION INCREASED 285 0.0094
786 CYANOSIS 148 0.0094
787 OFF LABEL USE 8240 0.0094
788 DEVICE OCCLUSION 132 0.0094
789 ACUTE MYELOID LEUKAEMIA 144 0.0092
790 INTENTIONAL PRODUCT MISUSE 808 0.0092
791 BEDRIDDEN 121 0.0092
792 SPEECH DISORDER 482 0.0092
793 SKIN REACTION 129 0.0091
794 TENDON RUPTURE 113 0.0091
795 AGRANULOCYTOSIS 170 0.0091
796 DYSKINESIA 371 0.0091
797 CARDIO-RESPIRATORY ARREST 381 0.0091
798 GINGIVAL BLEEDING 124 0.0091
799 DRUG INTERACTION 1434 0.0090
800 INTENTIONAL DOSE OMISSION 257 0.0090
801 HAIR COLOUR CHANGES 112 0.0090
802 LUNG INFECTION 139 0.0089
803 COGNITIVE DISORDER 417 0.0089
804 METASTASES TO CENTRAL NERVOUS SYSTEM 115 0.0089
805 NERVOUSNESS 463 0.0089
806 STEVENS-JOHNSON SYNDROME 197 0.0089
807 SENSORY DISTURBANCE 142 0.0088
808 SKIN DISCOLOURATION 405 0.0088
809 THERAPEUTIC RESPONSE SHORTENED 292 0.0088
810 ERYTHEMA 1809 0.0088
811 THROAT TIGHTNESS 238 0.0088
812 AGEUSIA 219 0.0088
813 DYSGEUSIA 651 0.0088
814 HALLUCINATION, VISUAL 185 0.0088
815 CARDIAC ARREST 722 0.0087
816 INCREASED APPETITE 167 0.0087
817 FEELING ABNORMAL 2093 0.0087
818 RHABDOMYOLYSIS 363 0.0087
819 UVEITIS 118 0.0087
820 DEAFNESS 227 0.0087
821 VISION BLURRED 1188 0.0086
822 GLAUCOMA 166 0.0086
823 SKIN FISSURES 168 0.0086
824 MUSCLE TWITCHING 198 0.0086
825 SKIN DISORDER 286 0.0086
826 OSTEONECROSIS OF JAW 212 0.0086
827 PROSTATIC SPECIFIC ANTIGEN INCREASED 118 0.0086
828 LYMPHOMA 132 0.0085
829 PRURITUS GENERALISED 184 0.0085
830 CEREBRAL HAEMORRHAGE 304 0.0085
831 LOCAL SWELLING 147 0.0084
832 EYE SWELLING 313 0.0084
833 THERAPEUTIC RESPONSE DECREASED 510 0.0084
834 SKIN CANCER 181 0.0084
835 PRODUCT USE IN UNAPPROVED INDICATION 2075 0.0084
836 ELECTROCARDIOGRAM QT PROLONGED 301 0.0084
837 MULTIPLE ORGAN DYSFUNCTION SYNDROME 237 0.0084
838 SOMNOLENCE 1683 0.0084
839 THIRST 149 0.0083
840 TREATMENT NONCOMPLIANCE 456 0.0083
841 MENTAL DISORDER 362 0.0083
842 COLON CANCER 123 0.0082
843 ANGIOEDEMA 365 0.0082
844 BLOOD CREATINE PHOSPHOKINASE INCREASED 237 0.0082
845 PHARMACEUTICAL PRODUCT COMPLAINT 212 0.0082
846 PARALYSIS 116 0.0081
847 IMPAIRED WORK ABILITY 173 0.0081
848 NEOPLASM PROGRESSION 281 0.0081
849 RASH MACULAR 281 0.0080
850 NEUTROPENIA 1090 0.0080
851 INTERSTITIAL LUNG DISEASE 388 0.0080
852 PRODUCT USE COMPLAINT 126 0.0080
853 LYMPHOPENIA 113 0.0080
854 DISEASE PROGRESSION 944 0.0080
855 DIABETIC KETOACIDOSIS 191 0.0079
856 PRODUCT DOSE OMISSION IN ERROR 224 0.0079
857 EYE IRRITATION 454 0.0079
858 ABASIA 194 0.0078
859 HALLUCINATION 589 0.0078
860 SKIN EXFOLIATION 657 0.0078
861 CRYING 283 0.0078
862 PRODUCT DOSE OMISSION ISSUE 2288 0.0078
863 PRODUCT ADMINISTRATION ERROR 155 0.0077
864 HYPERTHYROIDISM 111 0.0077
865 HOSPITALISATION 1167 0.0076
866 HAEMORRHAGE 793 0.0076
867 BLOOD GLUCOSE DECREASED 363 0.0076
868 EMOTIONAL DISORDER 233 0.0075
869 OCULAR HYPERAEMIA 358 0.0075
870 ECZEMA 394 0.0075
871 GLYCOSYLATED HAEMOGLOBIN INCREASED 190 0.0075
872 THERAPY PARTIAL RESPONDER 117 0.0075
873 HAEMORRHAGE INTRACRANIAL 112 0.0075
874 MUSCULOSKELETAL DISORDER 142 0.0075
875 SURGERY 437 0.0074
876 PERITONITIS 154 0.0074
877 SHOCK 171 0.0074
878 DEPRESSED MOOD 393 0.0074
879 FACE OEDEMA 125 0.0074
880 PHARYNGEAL OEDEMA 114 0.0074
881 THINKING ABNORMAL 138 0.0074
882 MENTAL IMPAIRMENT 179 0.0074
883 DEPRESSED LEVEL OF CONSCIOUSNESS 292 0.0074
884 DERMATITIS 154 0.0073
885 PARANOIA 125 0.0072
886 AGITATION 532 0.0072
887 DISTURBANCE IN ATTENTION 390 0.0072
888 EYE DISORDER 237 0.0072
889 RASH GENERALISED 185 0.0071
890 HEPATOTOXICITY 158 0.0071
891 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 164 0.0070
892 HYPOACUSIS 302 0.0070
893 CEREBRAL INFARCTION 171 0.0070
894 PELVIC PAIN 127 0.0070
895 RASH PAPULAR 155 0.0069
896 ANAPHYLACTIC REACTION 379 0.0069
897 DRUG INEFFECTIVE 9034 0.0068
898 MALIGNANT NEOPLASM PROGRESSION 693 0.0068
899 BONE MARROW FAILURE 137 0.0067
900 DEATH 5760 0.0067
901 BLOOD GLUCOSE INCREASED 1250 0.0066
902 NERVOUS SYSTEM DISORDER 207 0.0066
903 BONE DENSITY DECREASED 206 0.0066
904 NEOPLASM MALIGNANT 434 0.0065
905 ABNORMAL DREAMS 178 0.0064
906 MULTIPLE SCLEROSIS 308 0.0064
907 SUICIDAL IDEATION 587 0.0064
908 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 351 0.0064
909 FRACTURE 121 0.0064
910 UNDERDOSE 462 0.0063
911 SEIZURE 726 0.0063
912 RESPIRATORY ARREST 173 0.0063
913 TARDIVE DYSKINESIA 177 0.0063
914 COMA 298 0.0063
915 THERAPY INTERRUPTED 446 0.0062
916 BLOOD GLUCOSE ABNORMAL 115 0.0062
917 NIGHTMARE 212 0.0061
918 EYE PRURITUS 204 0.0061
919 MOOD ALTERED 165 0.0060
920 EMOTIONAL DISTRESS 730 0.0060
921 VISUAL ACUITY REDUCED 199 0.0060
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 215 0.0059
923 LUNG NEOPLASM MALIGNANT 240 0.0058
924 DRUG EFFECT DECREASED 312 0.0058
925 SEDATION 150 0.0057
926 THERAPY CESSATION 294 0.0057
927 THERAPEUTIC RESPONSE UNEXPECTED 256 0.0057
928 DRY SKIN 759 0.0057
929 PAIN OF SKIN 152 0.0056
930 OSTEONECROSIS 185 0.0056
931 ERECTILE DYSFUNCTION 144 0.0056
932 PRODUCT QUALITY ISSUE 758 0.0056
933 DISEASE RECURRENCE 260 0.0055
934 BLINDNESS 221 0.0054
935 TOOTH LOSS 112 0.0054
936 INJECTION SITE BRUISING 425 0.0053
937 MULTIPLE SCLEROSIS RELAPSE 362 0.0053
938 LACTIC ACIDOSIS 171 0.0053
939 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 135 0.0052
940 ACCIDENTAL OVERDOSE 191 0.0052
941 AGGRESSION 259 0.0052
942 ANGER 172 0.0051
943 ABNORMAL BEHAVIOUR 201 0.0051
944 SUICIDE ATTEMPT 307 0.0051
945 PRODUCT AVAILABILITY ISSUE 114 0.0050
946 PRODUCT SUBSTITUTION ISSUE 288 0.0050
947 LIP SWELLING 166 0.0050
948 INJECTION SITE RASH 152 0.0049
949 DRUG DOSE OMISSION 818 0.0049
950 INJECTION SITE PAIN 1517 0.0049
951 IRRITABILITY 297 0.0049
952 ANAPHYLACTIC SHOCK 127 0.0049
953 PRODUCT DOSE OMISSION 319 0.0049
954 DRUG ADMINISTRATION ERROR 148 0.0048
955 DEVICE DISLOCATION 208 0.0048
956 INCORRECT DOSE ADMINISTERED 1092 0.0048
957 MOOD SWINGS 149 0.0047
958 INJECTION SITE ERYTHEMA 572 0.0046
959 NEEDLE ISSUE 134 0.0046
960 PSYCHOTIC DISORDER 135 0.0046
961 INJECTION SITE SWELLING 347 0.0045
962 INJECTION SITE PRURITUS 303 0.0045
963 EXTRAPYRAMIDAL DISORDER 111 0.0045
964 DEVICE ISSUE 398 0.0044
965 WITHDRAWAL SYNDROME 185 0.0044
966 OVERDOSE 936 0.0043
967 INCORRECT DRUG ADMINISTRATION DURATION 122 0.0043
968 DRUG DEPENDENCE 695 0.0043
969 PANCREATIC CARCINOMA 124 0.0043
970 EXPOSURE VIA SKIN CONTACT 111 0.0043
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 303 0.0043
972 DRUG EFFECT INCOMPLETE 152 0.0042
973 VAGINAL HAEMORRHAGE 174 0.0040
974 HEPATIC FUNCTION ABNORMAL 149 0.0040
975 INJECTION SITE HAEMORRHAGE 317 0.0040
976 ACNE 296 0.0039
977 INJECTION SITE MASS 134 0.0036
978 INJECTION SITE REACTION 240 0.0035
979 DEVICE MALFUNCTION 240 0.0034
980 DEVICE LEAKAGE 140 0.0032
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 653 0.0032
982 DRUG WITHDRAWAL SYNDROME 266 0.0030
983 SKIN BURNING SENSATION 210 0.0029
984 DERMATITIS ATOPIC 154 0.0029
985 SKIN IRRITATION 128 0.0028
986 FOETAL EXPOSURE DURING PREGNANCY 189 0.0023
987 BREAST CANCER 212 0.0023
988 TOXICITY TO VARIOUS AGENTS 383 0.0023
989 INTENTIONAL OVERDOSE 135 0.0021
990 NO ADVERSE EVENT 378 0.0021
991 ACCIDENTAL EXPOSURE TO PRODUCT 208 0.0020
992 DRUG ABUSE 167 0.0020
993 PROSTATE CANCER 159 0.0020